Cyclerion Therapeutics, Inc.

Cyclerion Therapeutics, Inc.verified

CYCN

Price:

$3.3

Market Cap:

$14.29M

Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's disease with vascular pathology; and Phase 1 trials diagnosed with schizophrenia in adults. It is also developing Praliciguat, an orally administered systemic sGC stimulator, which is in Phase II studies to treat resistant hypertension and diabetic neph...[Read more]

Industry

Biotechnology

IPO Date

2019-03-18

Stock Exchange

NASDAQ

Ticker

CYCN

The Enterprise Value as of April 2026 (TTM) for Cyclerion Therapeutics, Inc. (CYCN) is 11.05M

According to Cyclerion Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.05M. This represents a change of 256.83% compared to the average of 3.10M of the last 4 quarters.

Cyclerion Therapeutics, Inc. (CYCN) Historical Enterprise Value (quarterly & annually)

How has CYCN Enterprise Value performed in the past?

The mean historical Enterprise Value of Cyclerion Therapeutics, Inc. over the last ten years is 85.23M. The current 11.05M Enterprise Value has changed 1.20% with respect to the historical average. Over the past ten years (40 quarters), CYCN's Enterprise Value was at its highest in in the March 2019 quarter at 625.63M. The Enterprise Value was at its lowest in in the June 2022 quarter at -7632083.36.

Quarterly (TTM)
Annual

Average

85.23M

Median

14.25M

Minimum

0

Maximum

341.31M

Cyclerion Therapeutics, Inc. (CYCN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cyclerion Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual Enterprise Value = 341.31M

Minimum Annual Increase = -98.27%

Minimum Annual Enterprise Value = 0

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025855.75K-82.45%
20244.88M1.77%
2023261.30K-98.27%
202215.13M13.18%
202113.37M-84.16%
202084.37M66.09%
201950.80M-85.12%
2018341.31M0.00%
2017341.30MInfinity%

Cyclerion Therapeutics, Inc. (CYCN) Average Enterprise Value

How has CYCN Enterprise Value performed in the past?

The current Enterprise Value of Cyclerion Therapeutics, Inc. (CYCN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

2.00M

5-year avg

6.90M

10-year avg

85.23M

Cyclerion Therapeutics, Inc. (CYCN) Enterprise Value vs. Peers

How is CYCN’s Enterprise Value compared to its peers?

Cyclerion Therapeutics, Inc.’s Enterprise Value is greater than Alaunos Therapeutics, Inc. (4.66M), greater than XTL Biopharmaceuticals Ltd. (7.46M), less than Polyrizon Ltd. (15.81M), greater than Quoin Pharmaceuticals, Ltd. (-3814443489.00), greater than Pasithea Therapeutics Corp. (-50025342.00), greater than Radiopharm Theranostics Limited (-21444253.97), greater than VYNE Therapeutics Inc. (-13348132.00), less than NovaBay Pharmaceuticals, Inc. (26.37M), greater than Addex Therapeutics Ltd (5.33M), greater than AIM ImmunoTech Inc. (5.75M),

Build a custom stock screener for Cyclerion Therapeutics, Inc. (CYCN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyclerion Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cyclerion Therapeutics, Inc. (CYCN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cyclerion Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Cyclerion Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Cyclerion Therapeutics, Inc. (CYCN)?

What is the 3-year average Enterprise Value for Cyclerion Therapeutics, Inc. (CYCN)?

What is the 5-year average Enterprise Value for Cyclerion Therapeutics, Inc. (CYCN)?

How does the current Enterprise Value for Cyclerion Therapeutics, Inc. (CYCN) compare to its historical average?